REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Halagel Plant (M) Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Halagel Plant (M) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Halagel Plant (M) Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Sungai Petani. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on September 25, 2004. In its most recent financial highlights, the company reported a net sales revenue drop of 15.48% in 2022. Its total assets decreased by 2.11% over the same period. The net profit margin of Halagel Plant (M) Sdn. Bhd. decreased by 12.25% in 2022.

Headquarters
Lot A-137 Jalan 2B, Kawasan Perusahaan Miel, Sungai Lalang
Sungai Petani; Kedah; Postal Code: 08000

Contact Details: Purchase the Halagel Plant (M) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Halagel Plant (M) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Halagel Plant (M) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Halagel Plant (M) Sdn. Bhd. report to view the information.
Incorporation Date:
September 25, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Halagel Plant (M) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-15.48%▼
Total operating revenue
-15.48%▼
Operating profit (EBIT)
-45.96%▼
EBITDA
-42.36%▼
Net Profit (Loss) for the Period
-45.96%▼
Total assets
-2.11%▼
Total equity
15.81%▲
Operating Profit Margin (ROS)
-12.25%▼
Net Profit Margin
-12.25%▼
Return on Equity (ROE)
10.47%▲
Debt to Equity Ratio
10.67%▲
Quick Ratio
0.02%▲
Cash Ratio
-0%

Similar companies

Vance Bioenergy Sdn. Bhd.
 
Pfizer (Malaysia) Sdn. Bhd.
Caring Pharmacy Group Berhad
 
Apex Healthcare Bhd
Abbott Laboratories (Malaysia) Sdn. Bhd.
 
Bayer Co. (Malaysia) Sdn. Bhd.
Kpj Healthshoppe Sdn. Bhd.
 
Ok Health Group (Malaysia) Sdn. Bhd.
Damai Rx Sdn. Bhd.
 
Nexus Bioceuticals Sdn. Bhd.
Lifestrands Genomics Sdn. Bhd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo